FDA Adverse Event Injury Summary report: N

PEDICSCR MATRIX POLYAXIAL Ø6 PREASSMBL C

MDR report key: 2954680 · Received February 11, 2013

Report

Report Number
2530088-2013-00133
Event Type
Injury
Date Received
February 11, 2013
Report Date
January 14, 2013
Manufacturer
SYNTHES BRANDYWINE
Product Code
NKB
PMA / PMN Number
K100952
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SZ
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

DEVICE WAS USED FOR TREATMENT, NOT DIAGNOSIS. SUBJECT DEVICE HAS BEEN RECEIVED AND IS CURRENTLY IN THE EVALUATION PROCESS. INVESTIGATION IS ON GOING. A REVIEW OF THE DEVICE HISTORY RECORD IS BEING CONDUCTED, RESULTS PENDING. PLACEHOLDER.

Additional Manufacturer Narrative · 1

THIS DEVICE IS USED FOR TREATMENT, NOT DIAGNOSIS. REVIEW OF THE DHRS SHOWED THERE WERE NO ISSUES DURING THE MANUFACTURE THAT WOULD CONTRIBUTE TO THIS COMPLAINT CONDITION. THE INVESTIGATION HAS SHOWN THAT THE COMPLAINED IMPLANTS PRESENTS SIGNS OF USE SUCH AS MARKS AND SCRATCHES, WHICH AROSE FROM THE HANDLING DURING IMPLANTATION / REMOVAL. THE REVIEW OF THE PRODUCTION HISTORY REVEALED THAT THE CONCERNED LOCKING CAPPEDICLE, THE PEDICLE SCREW AND THE ROD WERE MANUFACTURED IN THE YEAR 2012 ACCORDING TO THE SPECIFICATIONS. UNFORTUNATELY THE EXACT CAUSE OF FAILURE COULD NOT BE DETERMINED. A POSSIBLE FAILURE REASON COULD BE THAT DURING THE FINAL TIGHTENING THE SCREW HEADS WERE NOT PERPENDICULAR TO THE ROD. THE DESIRED ORIENTATION OF THE SCREW HEAD CAN BE ACHIEVED BY A VERTICAL ALIGNMENT OF THE COUNTER TORQUE IN RELATION TO THE ROD.

Description of Event or Problem · 1

DEVICE REPORT FROM SYNTHES EUROPE REPORTS AN EVENT IN (B)(6) AS FOLLOWS: THE LOCKING CAP OF THE MATRIX PEDICLE SCREW BECAME LOOSE. THE DEVICE WAS EXPLANTED ON (B)(6) 2013. THIS IS 3 OF 3 REPORTS FOR THE SAME EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
58050 PEDICSCR MATRIX POLYAXIAL Ø6 PREASSMBL C ORTHOSIS, SPINAL PEDICLE FIXATION, FOR DDD NKB SYNTHES BRANDYWINE 6952153

Patients

Seq Age Sex Outcome Treatment
1 74 YR Required Intervention